351 related articles for article (PubMed ID: 12842434)
21. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition.
Zayed H; Izsvák Z; Khare D; Heinemann U; Ivics Z
Nucleic Acids Res; 2003 May; 31(9):2313-22. PubMed ID: 12711676
[TBL] [Abstract][Full Text] [Related]
22. Sleeping beauty transposon-mediated gene therapy for prolonged expression.
Hackett PB; Ekker SC; Largaespada DA; McIvor RS
Adv Genet; 2005; 54():189-232. PubMed ID: 16096013
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.
Yant SR; Park J; Huang Y; Mikkelsen JG; Kay MA
Mol Cell Biol; 2004 Oct; 24(20):9239-47. PubMed ID: 15456893
[TBL] [Abstract][Full Text] [Related]
24. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
[TBL] [Abstract][Full Text] [Related]
25.
Kovač A; Miskey C; Ivics Z
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834425
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Izsvák Z; Ivics Z; Bowers WJ
Hum Gene Ther; 2010 Nov; 21(11):1603-13. PubMed ID: 20507234
[TBL] [Abstract][Full Text] [Related]
27. Generation of trangenic Xenopus laevis using the Sleeping Beauty transposon system.
Sinzelle L; Vallin J; Coen L; Chesneau A; Du Pasquier D; Pollet N; Demeneix B; Mazabraud A
Transgenic Res; 2006 Dec; 15(6):751-60. PubMed ID: 16957880
[TBL] [Abstract][Full Text] [Related]
28. Design of a nonviral vector for site-selective, efficient integration into the human genome.
Kaminski JM; Huber MR; Summers JB; Ward MB
FASEB J; 2002 Aug; 16(10):1242-7. PubMed ID: 12153992
[TBL] [Abstract][Full Text] [Related]
29. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system.
Belur LR; Frandsen JL; Dupuy AJ; Ingbar DH; Largaespada DA; Hackett PB; Scott McIvor R
Mol Ther; 2003 Sep; 8(3):501-7. PubMed ID: 12946324
[TBL] [Abstract][Full Text] [Related]
30. Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors.
Moldt B; Yant SR; Andersen PR; Kay MA; Mikkelsen JG
Hum Gene Ther; 2007 Dec; 18(12):1193-204. PubMed ID: 17988194
[TBL] [Abstract][Full Text] [Related]
31. Liver-directed gene therapy using the sleeping beauty transposon system.
Belur LR; McIvor RS; Wilber A
Methods Mol Biol; 2008; 434():267-76. PubMed ID: 18470650
[TBL] [Abstract][Full Text] [Related]
32. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
[TBL] [Abstract][Full Text] [Related]
33. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Huang X; Haley K; Wong M; Guo H; Lu C; Wilber A; Zhou X
Hum Gene Ther; 2010 Nov; 21(11):1577-90. PubMed ID: 20528476
[TBL] [Abstract][Full Text] [Related]
34. Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.
Izsvák Z; Hackett PB; Cooper LJ; Ivics Z
Bioessays; 2010 Sep; 32(9):756-67. PubMed ID: 20652893
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.
Huang X; Guo H; Tammana S; Jung YC; Mellgren E; Bassi P; Cao Q; Tu ZJ; Kim YC; Ekker SC; Wu X; Wang SM; Zhou X
Mol Ther; 2010 Oct; 18(10):1803-13. PubMed ID: 20606646
[TBL] [Abstract][Full Text] [Related]
36. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon.
Hollis RP; Nightingale SJ; Wang X; Pepper KA; Yu XJ; Barsky L; Crooks GM; Kohn DB
Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326
[TBL] [Abstract][Full Text] [Related]
37. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.
Izsvák Z; Chuah MK; Vandendriessche T; Ivics Z
Methods; 2009 Nov; 49(3):287-97. PubMed ID: 19615447
[TBL] [Abstract][Full Text] [Related]
38. Transposon-independent increase of transcription by the Sleeping Beauty transposase.
Masuda K; Yamamoto S; Endoh M; Kaneda Y
Biochem Biophys Res Commun; 2004 May; 317(3):796-800. PubMed ID: 15081410
[TBL] [Abstract][Full Text] [Related]
39. Sleeping beauty transposition from nonintegrating lentivirus.
Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
[TBL] [Abstract][Full Text] [Related]
40. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
